Next Century Growth Investors’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-189,185
Closed -$10.9M 143
2025
Q2
$10.9M Buy
189,185
+62,112
+49% +$3.51M 0.84% 42
2025
Q1
$7.4M Sell
127,073
-159,864
-56% -$10.9M 0.66% 56
2024
Q4
$23.1M Buy
286,937
+11,857
+4% +$1.01M 1.73% 11
2024
Q3
$22M Buy
275,080
+35,489
+15% +$2.52M 1.79% 13
2024
Q2
$14.6M Buy
239,591
+150,051
+168% +$8.92M 1.22% 25
2024
Q1
$4.43M Buy
89,540
+26,964
+43% +$1.28M 0.38% 77
2023
Q4
$2.62M Sell
62,576
-66,892
-52% -$2.28M 0.26% 91
2023
Q3
$4.25M Buy
129,468
+25,818
+25% +$880K 0.46% 57
2023
Q2
$3.66M Buy
103,650
+47,862
+86% +$1.58M 0.35% 70
2023
Q1
$1.58M Buy
+55,788
New +$1.97M 0.17% 86

Other funds holding PRCT

Next Century Growth Investors's PRCT Position: Q3 2025 in Review

Next Century Growth Investors sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 189,185 shares — an estimated $10.9M sold.

Next Century Growth Investors first reported a position in PRCT in Q1 2023 and held it in 10 quarters. The position peaked at $23.1M in Q4 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Next Century Growth Investors reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Next Century Growth Investors sold 189,185 Procept Biorobotics shares in Q3 2025, an estimated $10.9M.
  • Next Century Growth Investors first reported a position in Procept Biorobotics in Q1 2023 and held it in 10 quarters.
  • Next Century Growth Investors's Procept Biorobotics position peaked at $23.1M in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Next Century Growth Investors's 13F filing for Q3 2025, filed 14 Nov 2025.